Patients with Severe Eosinophilic Asthma, CRSwNP More Likely to Achieve Remission with Benralizumab
A post hoc analysis shows benralizumab was even more efficacious in patients with concomitant nasal polyps at both 6 and 12 months.
Source: hcplive.com